Human DOCK2 Deficiency: Report of a Novel Mutation and Evidence for Neutrophil Dysfunction.
Alternative Splicing
/ genetics
B-Lymphocytes
/ immunology
GTPase-Activating Proteins
/ genetics
Guanine Nucleotide Exchange Factors
/ genetics
Humans
Killer Cells, Natural
/ immunology
Neutrophils
/ immunology
Oxidative Stress
Pedigree
Sequence Deletion
/ genetics
Severe Combined Immunodeficiency
/ genetics
DOCK2
neutrophil dysfunction
Journal
Journal of clinical immunology
ISSN: 1573-2592
Titre abrégé: J Clin Immunol
Pays: Netherlands
ID NLM: 8102137
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
received:
07
11
2018
accepted:
18
02
2019
pubmed:
7
3
2019
medline:
7
7
2020
entrez:
7
3
2019
Statut:
ppublish
Résumé
DOCK2 is a guanine-nucleotide-exchange factor for Rac proteins. Activated Rac serves various cellular functions including the reorganization of the actin cytoskeleton in lymphocytes and neutrophils and production of reactive oxygen species in neutrophils. Since 2015, six unrelated patients with combined immunodeficiency and early-onset severe viral infections caused by bi-allelic loss-of-function mutations in DOCK2 have been described. Until now, the function of phagocytes, specifically neutrophils, has not been assessed in human DOCK2 deficiency. Here, we describe a new kindred with four affected siblings harboring a homozygous splice-site mutation (c.2704-2 A > C) in DOCK2. The mutation results in alternative splicing and a complete loss of DOCK2 protein expression. The patients presented with leaky severe combined immunodeficiency or Omenn syndrome. The novel mutation affects EBV-B cell migration and results in NK cell dysfunction similar to previous observations. Moreover, both cytoskeletal rearrangement and reactive oxygen species production are partially impaired in DOCK2-deficient neutrophils.
Identifiants
pubmed: 30838481
doi: 10.1007/s10875-019-00603-w
pii: 10.1007/s10875-019-00603-w
pmc: PMC6647034
mid: NIHMS1041545
doi:
Substances chimiques
DOCK2 protein, human
0
GTPase-Activating Proteins
0
Guanine Nucleotide Exchange Factors
0
Types de publication
Journal Article
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
298-308Subventions
Organisme : Intramural NIH HHS
ID : Z99 AI999999
Pays : United States
Références
Immunity. 1999 Feb;10(2):183-96
pubmed: 10072071
Biochim Biophys Acta. 1999 Nov 11;1452(2):179-87
pubmed: 10559471
Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4654-9
pubmed: 10758162
Blood. 2000 Sep 1;96(5):1646-54
pubmed: 10961859
Nature. 2001 Aug 23;412(6849):826-31
pubmed: 11518968
J Virol. 2002 Mar;76(6):3072-7
pubmed: 11861876
Mol Pharmacol. 2002 Jul;62(1):173-80
pubmed: 12065768
Immunity. 2003 Jul;19(1):119-29
pubmed: 12871644
Curr Opin Immunol. 2003 Oct;15(5):585-91
pubmed: 14499269
Science. 2003 Oct 17;302(5644):445-9
pubmed: 14564009
N Engl J Med. 2003 Nov 6;349(19):1821-8
pubmed: 14602880
Immunity. 2004 Sep;21(3):429-41
pubmed: 15357953
Trends Cell Biol. 2005 Mar;15(3):163-71
pubmed: 15752980
J Cell Biol. 2006 Aug 28;174(5):647-52
pubmed: 16943182
Blood. 2008 Mar 1;111(5):2597-605
pubmed: 18089848
Mol Pharmacol. 2008 Aug;74(2):485-95
pubmed: 18469140
Nat Rev Mol Cell Biol. 2008 Sep;9(9):690-701
pubmed: 18719708
Clin Immunol. 2009 Apr;131(1):24-30
pubmed: 19097825
Nucleic Acids Res. 2009 May;37(9):e67
pubmed: 19339519
J Biol Chem. 2009 Sep 4;284(36):24088-97
pubmed: 19586920
Dis Markers. 2010;29(3-4):151-6
pubmed: 21178274
J Exp Med. 2012 Jan 16;209(1):29-34
pubmed: 22231303
J Allergy Clin Immunol. 2013 Jun;131(6):1594-603
pubmed: 23522482
Blood. 2013 Jul 18;122(3):386-93
pubmed: 23719299
Clin Exp Immunol. 2014 Feb;175(2):139-49
pubmed: 24016250
J Allergy Clin Immunol. 2014 Apr;133(4):1092-8
pubmed: 24290292
Eur J Cell Biol. 2014 Oct;93(10-12):466-77
pubmed: 25022758
J Immunol. 2014 Dec 1;193(11):5660-7
pubmed: 25339677
J Allergy Clin Immunol. 2015 May;135(5):1380-4.e1-5
pubmed: 25512081
J Clin Immunol. 2015 Feb;35(2):100-7
pubmed: 25666293
N Engl J Med. 2015 Jun 18;372(25):2409-22
pubmed: 26083206
Sci Rep. 2016 Jun 13;6:27814
pubmed: 27291827
Blood. 2016 Oct 27;128(17):2135-2143
pubmed: 27557945
J Clin Invest. 2016 Oct 3;126(10):3837-3851
pubmed: 27599296
J Allergy Clin Immunol. 2016 Oct;138(4):957-969
pubmed: 27720020
Front Immunol. 2017 Sep 22;8:1126
pubmed: 29018439
Cell Rep. 2017 Nov 28;21(9):2541-2557
pubmed: 29186690
J Clin Immunol. 2018 Jan;38(1):10-12
pubmed: 29204803
Blood. 2018 Jan 25;131(4):439-449
pubmed: 29371208
Eur J Clin Invest. 2018 Nov;48 Suppl 2:e12939
pubmed: 29682742
J Allergy Clin Immunol. 2018 Nov;142(5):1589-1604.e11
pubmed: 29751004
Blood. 2018 Nov 29;132(22):2362-2374
pubmed: 30254128
J Comput Biol. 1997 Fall;4(3):311-23
pubmed: 9278062
J Immunol. 1998 Jul 15;161(2):1026-33
pubmed: 9670984
J Immunol. 1998 Nov 1;161(9):4968-74
pubmed: 9794433